🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will examine the safety and efficacy of the addition of sitaglip...
Status
Completed
Location
Multiple Locations
Start Date
2009-04-15
Trial ID
NCT00885352
Treatments Being Tested
This is a 24 week study comparing the efficacy of four dose levels of INT13...
Status
Completed
Location
Northern California Research
Start Date
2008-02
Trial ID
NCT00631007
Treatments Being Tested
The purpose of this clinical research study is to learn if BMS-512148 (Dapa...
Status
Completed
Location
Local Institution
Start Date
2010-06
Trial ID
NCT01095666
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of sitagli...
Status
Completed
Location
Multiple Locations
Start Date
2008-01-15
Trial ID
NCT00541450
The purpose of this study is to determine the safety, tolerability and effi...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-01
Trial ID
NCT00849056
Treatments Being Tested
This study will compare the efficacy and safety of exenatide versus placebo...
Status
Completed
Location
Research Site
Start Date
2008-10
Trial ID
NCT00765817
Secondary failure of sulfonylureas (SUs) can occur in about 30%-40% of type...
Status
Completed
Location
Tongji Hospital
Start Date
2012-01
Trial ID
NCT02099838
Treatments Being Tested
The purpose of the study is to determine the efficacy of alogliptin compare...
Status
Completed
Location
Multiple Locations
Start Date
2010-12
Trial ID
NCT01289119
Treatments Being Tested
The purpose of this study is to determine the Anti-Inflammation Effects of ...
Status
Completed
Location
Multiple Locations
Start Date
2008-05
Trial ID
NCT00770445
Treatments Being Tested
This study will investigate the efficacy and safety of BI 10773 in type 2 d...
Status
Completed
Location
1245.19.10056 Boehringer Ingelheim Investigational Site
Start Date
2010-09
Trial ID
NCT01210001